|Slideshows|August 1, 2019

How Trazodone Can Cause Depression

Some patients get more depressed on this antidepressant, but that does not mean they have bipolar disorder.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Antidepressant Use in Pregnancy & Autism/ADHD in Children: Most Comprehensive Study to Date Finds No Clear Link

ByLeah Kuntz

May 14th 2026

Treatment of Inflammation to Relieve Depression and Anhedonia

ByKenneth J. Bender, PharmD, MA

May 12th 2026

Podcast: Psychedelics for Depression and Other Mental Health Conditions. The Way Forward With Guy Goodwin, MD

ByJoseph F. Goldberg, MD,Guy Goodwin, MD

May 8th 2026

The SAINT Trial: Expanding rTMS for Postpartum Depression

ByThalia Robakis, MD, PhD

April 30th 2026

Investigating the Effect of Psilocybin in Treatment-Resistant Depression

ByKenneth J. Bender, PharmD, MA

April 29th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

How Trazodone Can Cause Depression

Related Content

Antidepressant Use in Pregnancy & Autism/ADHD in Children: Most Comprehensive Study to Date Finds No Clear Link

Treatment of Inflammation to Relieve Depression and Anhedonia

Podcast: Psychedelics for Depression and Other Mental Health Conditions. The Way Forward With Guy Goodwin, MD

The SAINT Trial: Expanding rTMS for Postpartum Depression

Investigating the Effect of Psilocybin in Treatment-Resistant Depression

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

New Positive Phase 2 Topline Data on Elunetirom for the Treatment of Bipolar Depression

Adjunctive Atypical Antipsychotics in Major Depressive Disorder: Comparing Efficacy and Tolerability

Suicide Risk Assessment in Patients Denying Suicidal Intent

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research